More importantly, enhanced expression of AhR was found in tumor tissues from C-R patients with prostatic cancer (Fig. 2D), indicating that Kyn promoted AhR activation to mediate drugs resistance in prostatic cancer. Here, AHR is linked to prostate carcinoma.